Our findings demonstrated that the progressive decrease in DACH1 expression during CRC progression corresponds with a concurrent increase in promoter methylation, confirming that DNA methylation might be one of a critical mechanism driving DACH1 silencing in this context. This evidence concerns the gene DACH1 and colorectal carcinoma.